DE60118898D1 - Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen - Google Patents

Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen

Info

Publication number
DE60118898D1
DE60118898D1 DE60118898T DE60118898T DE60118898D1 DE 60118898 D1 DE60118898 D1 DE 60118898D1 DE 60118898 T DE60118898 T DE 60118898T DE 60118898 T DE60118898 T DE 60118898T DE 60118898 D1 DE60118898 D1 DE 60118898D1
Authority
DE
Germany
Prior art keywords
early treatment
recombinant
lung
acute
surfactant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118898T
Other languages
English (en)
Other versions
DE60118898T2 (de
Inventor
Dietrich Haefner
Andreas Keller
Frank Rathgeb
Peter Schaffer
Wilhelm Wurst
Christoph Karl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Application granted granted Critical
Publication of DE60118898D1 publication Critical patent/DE60118898D1/de
Publication of DE60118898T2 publication Critical patent/DE60118898T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60118898T 2000-04-12 2001-04-12 Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen Expired - Lifetime DE60118898T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00107858 2000-04-12
EP00107858 2000-04-12
PCT/EP2001/004223 WO2001076619A1 (en) 2000-04-12 2001-04-12 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases

Publications (2)

Publication Number Publication Date
DE60118898D1 true DE60118898D1 (de) 2006-05-24
DE60118898T2 DE60118898T2 (de) 2006-11-16

Family

ID=8168443

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118898T Expired - Lifetime DE60118898T2 (de) 2000-04-12 2001-04-12 Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen

Country Status (12)

Country Link
US (1) US20030158087A1 (de)
EP (1) EP1276495B1 (de)
JP (1) JP2003530356A (de)
AT (1) ATE323505T1 (de)
AU (1) AU2001265876A1 (de)
CA (1) CA2405811C (de)
DE (1) DE60118898T2 (de)
DK (1) DK1276495T3 (de)
ES (1) ES2262656T3 (de)
PT (1) PT1276495E (de)
SI (1) SI1276495T1 (de)
WO (1) WO2001076619A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
US6998384B2 (en) 2001-12-12 2006-02-14 The Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ITMI20021058A1 (it) 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
US7238664B2 (en) * 2003-06-16 2007-07-03 Altana Pharma Ag Composition comprising a pulmonary surfactant and a PDE5 inhibitor for the treatment of lung diseases
EP1781323B1 (de) 2004-08-06 2010-02-17 Nycomed GmbH Zusammensetzung aus einem pulmonalen surfactant und einem von tnf stammenden peptid
AU2010229668C1 (en) * 2009-03-26 2016-09-15 Pulmatrix Operating Co., Inc. Dry powder formulations and methods for treating pulmonary diseases
EP2407150A1 (de) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Nano- und Mikropolymerpartikel zur Aufrechterhaltung einer niedrigen Oberflächenspannung in der Lunge und zum Schutz des pulmonalen Surfactants

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013619A (en) * 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
GB9021080D0 (en) * 1990-09-26 1990-11-07 Univ Western Ontario Lipid extract surfactant and method of producing same
DE4418936A1 (de) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptid
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
WO1998052588A1 (fr) * 1997-05-21 1998-11-26 Medion Research Laboratories Inc. Agents therapeutiques adaptes a des affections respiratoires
DE19827907C2 (de) * 1998-06-23 2003-05-15 Altana Pharma Ag Neue pharmazeutische Zusammensetzungen zur Behandlung von IRDS und ARDS
ES2253003T3 (es) * 1998-11-10 2006-05-16 Altana Pharma Ag Equipo de tratamiento que contiene composiciones a base de agentes tensioactivos pulmonares.
ATE269101T1 (de) * 1999-01-19 2004-07-15 Altana Pharma Ag Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases

Also Published As

Publication number Publication date
SI1276495T1 (sl) 2006-10-31
DE60118898T2 (de) 2006-11-16
EP1276495A1 (de) 2003-01-22
AU2001265876A1 (en) 2001-10-23
ATE323505T1 (de) 2006-05-15
CA2405811C (en) 2011-09-27
EP1276495B1 (de) 2006-04-19
US20030158087A1 (en) 2003-08-21
ES2262656T3 (es) 2006-12-01
DK1276495T3 (da) 2006-08-14
CA2405811A1 (en) 2001-10-18
PT1276495E (pt) 2006-08-31
JP2003530356A (ja) 2003-10-14
WO2001076619A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
BR0316502A (pt) Compostos quìmicos
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
DE60009511D1 (de) Nematizide trifluorbutene
ATE424413T1 (de) Analoge des glucagon-ähnlichen peptids-1
GB0117326D0 (en) Napthoquinone-type inhibitors of protein aggregation
ATE363531T1 (de) Claudin polypeptide
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60211106D1 (de) Zusammensetzung zur Oxidationsfärbung von Keratinfasern
ATE343369T1 (de) Neue verwendung von proteinhydrolysaten
DE60232862D1 (de) Rekombinantes pockenvirus für chimäre proteine des menschlichen immunschwächevirus
DE60118898D1 (de) Verwendung von rekombinantem lungensurfactant zur frühbehandlung von akuten lungenerkrankungen
ATE323722T1 (de) Antimikrobiell wirkendes peptid
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
DE69737457D1 (de) O-fukosyltransferase
ATE320255T1 (de) Tie2 rezeptor-kinase-inhibitoren zur behandlung von angiogenen erkrankungen
DE60134885D1 (de) Antiangiogene polypeptide
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
ATE282609T1 (de) Neue substituierte n-methyl-n-(4-(4-(1h- benzimidazol-2-yl) (1,4)diazepan-1-yl)-2- (aryl)butyl)benzamide zur behandlung von allergischen krankheiten
DK1173194T3 (da) Rekombinant SP-A til behandlingen eller forebyggelsen af lungeinfektion og -inflammation
DE50214446D1 (de) Neue verwendung von lungensurfactant
DE60208365D1 (de) Verwendung von pyridoindolonderivaten zur herstellung von antikrebsmitteln
ATE314855T1 (de) Verwendung von cdp-cholin zur prophylaxe der cerebralen ischämie

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: NYCOMED GMBH, 78467 KONSTANZ, DE